Correlation Between Bristol Myers and Star Equity

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Star Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Star Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Star Equity Holdings, you can compare the effects of market volatilities on Bristol Myers and Star Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Star Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Star Equity.

Diversification Opportunities for Bristol Myers and Star Equity

0.08

Correlation Coefficient

Bristol Myers  Star Equity

Significant diversification

The 3 months correlation between Bristol and Star is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Star Equity Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Star Equity Holdings and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Star Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Star Equity Holdings has no effect on the direction of Bristol Myers i.e., Bristol Myers and Star Equity go up and down completely randomly.

Pair Corralation between Bristol Myers and Star Equity

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.42 times more return on investment than Star Equity. However, Bristol Myers Squibb is 2.4 times less risky than Star Equity. It trades about -0.01 of its potential returns per unit of risk. Star Equity Holdings is currently generating about -0.02 per unit of risk. If you would invest  6,355  in Bristol Myers Squibb on November 20, 2024 and sell it today you would lose (965.00) from holding Bristol Myers Squibb or give up 15.18% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Bristol Myers Squibb  vs.  Star Equity Holdings

Bristol Myers Squibb

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Bristol Myers is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Star Equity Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days Star Equity Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Bristol Myers and Star Equity

The main advantage of trading using opposite Bristol Myers and Star Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Star Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Star Equity will offset losses from the drop in Star Equity's long position.

The idea behind Bristol Myers Squibb and Star Equity Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.